According to a ranking by Statista and Newsweek, the best hospital in the United States is the *********** in Rochester, Minnesota. Moreover, the *********** was also ranked as the best hospital in the world, among over 50,000 hospitals in 30 countries. **************** in Ohio and the ************* Hospital in Maryland were ranked as second and third best respectively in the U.S., while they were second and forth best respectively in the World.

According to a ranking of the best hospitals in the U.S., the best hospital for adult cancer is the University of *******************************, which had a score of *** out of 100, as of 2025. This statistic shows the top 10 hospitals for adult cancer in the United States based on the score given by U.S. News and World Report's annual hospital ranking.

According to a ranking by Statista and Newsweek, the world's best hospital is the *********** in Rochester, Minnesota. A total of **** U.S. hospitals made it to the top ten list, while one hospital in each of the following countries was also ranked among the top ten best hospitals in the world: Canada, Sweden, Germany, Israel, Singapore, and Switzerland.

According to a ranking by Statista and Newsweek, the best hospital in Denmark is the Rigshospitalet - København in Copenhagen. Moreover, the Rigshospitalet - København was also ranked as the **** best hospital in the world, among over ****** hospitals in ** countries. Aarhus Universitetshospital in Aarhus and Odense Universitetshospital in Odense were ranked as second and third best respectively in the Denmark, while they were **** and **** best respectively in the World.

According to a ranking by Statista and Newsweek, the best hospital in Norway is Oslo Universitetssykehus in Oslo. Moreover, Oslo Universitetssykehus was also ranked as the **** best hospital in the world, among over ****** hospitals in ** countries. St. Olavs Hospital in Trondheim and Haukeland Universitetssykehus in Bergen were ranked as second and third best respectively in the Norway, while they were ***** and ***** best respectively in the World.

According to a ranking by Statista and Newsweek, the best hospital in Sweden is the Karolinska Universitetssjukhuset in Stockholm. Moreover, Karolinska Universitetssjukhuset was also ranked as the seventh-best hospital in the world, among over ****** hospitals in ** countries. Sahlgrenska Universitetssjukhuset in Göteborg and Akademiska Sjukhuset in Uppsala were ranked as second and third best respectively in the Sweden, while they were **** and **** best respectively in the World.

The average for 2020 based on 36 countries was 4.44 hospital beds. The highest value was in South Korea: 12.65 hospital beds and the lowest value was in Mexico: 0.99 hospital beds. The indicator is available from 1960 to 2021. Below is a chart for all countries where data are available.

According to a ranking by Statista and Newsweek, the best hospital in Finland is Helsinki University Hospital in Helsinki. Moreover, Helsinki University Hospital was also ranked as the **** best hospital in the world, among over ****** hospitals in ** countries. Tampere University Hospital in Tampere and Turku University Hospital in Turku were ranked as second and third best respectively in the Finland, while they were ***** and ***** best respectively in the World.

ContextResearch-oriented cancer hospitals in the United States treat and study patients with a range of diseases. Measures of disease specific research productivity, and comparison to overall productivity, are currently lacking.HypothesisDifferent institutions are specialized in research of particular diseases.ObjectiveTo report disease specific productivity of American cancer hospitals, and propose a summary measure.MethodWe conducted a retrospective observational survey of the 50 highest ranked cancer hospitals in the 2013 US News and World Report rankings. We performed an automated search of PubMed and Clinicaltrials.gov for published reports and registrations of clinical trials (respectively) addressing specific cancers between 2008 and 2013. We calculated the summed impact factor for the publications. We generated a summary measure of productivity based on the number of Phase II clinical trials registered and the impact factor of Phase II clinical trials published for each institution and disease pair. We generated rankings based on this summary measure.ResultsWe identified 6076 registered trials and 6516 published trials with a combined impact factor of 44280.4, involving 32 different diseases over the 50 institutions. Using a summary measure based on registered and published clinical trails, we ranked institutions in specific diseases. As expected, different institutions were highly ranked in disease-specific productivity for different diseases. 43 institutions appeared in the top 10 ranks for at least 1 disease (vs 10 in the overall list), while 6 different institutions were ranked number 1 in at least 1 disease (vs 1 in the overall list).ConclusionResearch productivity varies considerably among the sample. Overall cancer productivity conceals great variation between diseases. Disease specific rankings identify sites of high academic productivity, which may be of interest to physicians, patients and researchers.

According to cognitive market research-"Global Medical Disposables market size 2023 was XX Million. Medical Disposables Industry compound annual growth rate (CAGR) was XX% from 2024 till 2031."

  In 2023, the sterilisation supplies segment held the lead with XX% of total revenue. Infection control is critical in healthcare settings.
  The plastic resin segment dominated the market in 2023. Infection control is critical in healthcare settings.
  Hospitals dominated the market in 2023 because they provide a diverse range of medical services and treatments, including various medical specialties and procedures.
  North America accounted for XX% of the worldwide market in 2023 and is expected to maintain its dominance during the forecast period. North America boasts a highly developed and modern healthcare infrastructure, including hospitals, clinics, and medical facilities.

Current scenario of the Medical disposables market

Key drivers of the Medical Disposables market

An increase in hospital-acquired infections (HAIs) around the globe is fuelling market demand. 

HAI is becoming an increasingly serious issue in healthcare facilities around the world. According to the WHO, 10 out of every 100 hospital patients in developing countries and seven in industrialised nations suffer from HAIs. Infectious agents provide an elevated risk to health practitioners and professionals, and patients who are exposed are more likely to catch hospital-acquired diseases. According to statistical research published by the Centers for Disease Control and Prevention (CDC), such HAIs cause around 1.7 million diseases and more than 99,000 deaths in American hospitals. https://www.who.int/news/item/06-05-2022-who-launches-first-ever-global-report-on-infection-prevention-and-control#:~:text=Today%2C%20out%20of%20every%20100,will%20die%20from%20their%20HAI.

HAIs were listed among the top five leading causes of mortality. Surgical infections, urinary tract infections, lung infections, and bloodstream infections are some of the most common hospital-acquired infection types. According to the American Hospital Association, post-surgical bloodstream infections have grown by 8%, while urinary tract infections have increased by 3.6% as a result of catheter placement during surgery. As a result, the usage of medical disposables may play an important role in preventing cross-contamination and reducing the danger of infection spread, driving the market to higher standards. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501203/

Rising Diabetes Rates Will Drive Up market demand

Rapid urbanization and the growing trend towards sedentary lifestyles in both developed and emerging nations are the main causes of the increased prevalence of diabetes. According to the International Diabetes Federation, 537 million adults globally were predicted to have diabetes in 2021; 51.6% of those people were estimated to reside in China, India, the United States, Brazil, and Mexico. The rapid acceptance of these systems worldwide can be attributed to the large rise in the number of patients with type-1 or insulin-dependent type 2 diabetes. Type 1 diabetes affects around 149.5 out of every 1,000 children and teenagers worldwide, accounting for 9.8% of the total population. https://idf.org/about-diabetes/diabetes-facts-figures/ Long-term diabetes may result in foot ulcers, longer hospital stays, and a positive impact on the market during the forecast period. Despite the healthcare industry's careful efforts, many people contract hospital-acquired infections while being treated there. The Centres for Disease Control and Prevention (CDC) estimate that over 3% of patients in the United States contract hospital-acquired infections each year.

Constraints for the global Medical Disposables market

The increase in waste production limits market expansion.

The sustainable healthcare business requires effective biomedical waste management. Efficiency in processing the vast amount of generated biomedical waste became a work for the entire world, as well as a fight to manage the exuberant amount of garbage, with the outbreak of the COVID-19 pandemic, when hospitals and care centres were inundated with patients. Despite the fact that the bulk of medical waste poses no harm to human...

Hospitals play a critical role in healthcare, offering specialized treatments and emergency services essential for public health, regardless of economic fluctuations or individuals' financial situations. Rising incomes and broader access to insurance have fueled demand for care in recent years, supporting hospitals' post-pandemic recovery initiated by federal policies and funding. The recovery for many hospitals was also promoted by mergers that lessened financial strains, especially in rural hospitals. This trend toward consolidation has resulted in fewer enterprises relative to establishments, enhancing hospitals' bargaining power regarding input costs and insurance reimbursements. With this improved position, hospitals are expected to see revenue climb at a CAGR of 2.0%, reaching $1.5 trillion by 2025, with a 3.2% increase in 2025 alone. Competition, economic conditions and regulatory changes will impact hospitals based on size and location. Smaller hospitals, particularly rural ones, may encounter more significant obstacles as the industry transitions from fee-based to value-based care. Independent hospitals face wage inflation, staffing shortages and drug supply costs. Although state and federal policies aim to support small rural hospitals in addressing hospital deserts, uncertainties linger over federal Medicare funding and Medicaid reimbursements, which account for nearly half of hospital care spending. Even so, increasing per capita disposable income and increasing the number of individuals with private insurance will boost revenues from private insurers and out-of-pocket payments for all hospitals, big and small. Hospitals will continue incorporating technological advancements in AI, telemedicine and wearables to enhance their services and reduce cost. These technologies aid hospital systems in strategically expanding outpatient services, mitigating the increasing competitive pressures from Ambulatory Surgery Centers (ASCs) and capitalizing on the increased needs of an aging adult population and shifts in healthcare delivery preferences. As the consolidation trend advances and technology adoption further leverages economies of scale, industry revenue is expected to strengthen at a CAGR of 2.4%, reaching $1.7 trillion by 2030, with steady profit over the period.

According to a ranking of the best hospitals in the U.S., the best hospital for adult cardiology, heart, and vascular surgery is the ******************** in New York, which had a score of *** out of 100, as of 2025. This statistic shows the top 10 hospitals for adult cardiology, heart, and vascular surgery in the United States based on the score given by U.S. News and World Report's annual hospital ranking.

The point shapefile shows locations of the critical care hospitals in the lower 48 states compiled from Health Resource and Service Administration (HRSA) of Dept. of HHS, dataset. There are over 8000 records that have name, address, telephone numbers (where listed) and also number of certified and toal hospital beds available at these hospitals.

Hospital directory for Washington State CHARS Hospitals.

Postpartum hemorrhage (PPH) is the leading cause of maternal mortality in Kenya. The aim of this study was to measure quality and timeliness of care for PPH in a sample of deliveries in referral hospitals in Kenya. We conducted direct observations of 907 vaginal deliveries in three Kenyan hospitals from October 2018 through February 2019, observing the care women received from admission for labor and delivery through hospital discharge. We identified cases of “suspected PPH”, defined as cases in which providers indicated suspicion of and/or took an action to manage abnormal bleeding. We measured adherence to World Health Organization and Kenyan guidelines for PPH risk assessment, prevention, identification, and management and the timeliness of care in each domain. The rate of suspected PPH among the observed vaginal deliveries was 9% (95% Confidence Interval: 7% - 11%). Health care providers followed all guidelines for PPH risk assessment in 7% (5% - 10%) of observed deliveries and all guidelines for PPH prevention in 4% (3% - 6%) of observed deliveries. Lowest adherence was observed for taking vital signs and for timely administration of a prophylactic uterotonic. Providers did not follow guidelines for postpartum monitoring in any of the observed deliveries. When suspected PPH occurred, providers performed all recommended actions in 23% (6% - 40%) of cases. Many of the critical actions for suspected PPH were performed in a timely manner, but, in some cases, substantial delays were observed. In conclusion, we found significant gaps in the quality of risk assessment, prevention, identification, and management of PPH after vaginal deliveries in referral hospitals in Kenya. Efforts to reduce maternal morbidity and mortality from PPH should emphasize improvements in the quality of care, with a particular focus on postpartum monitoring and timely emergency response.

As of 2022, the largest hospital in the world was found in Henan, China. With seven thousand beds, First Affiliated Hospital of Zhengzhou University was ranked as the largest hospital globally according to its number of beds. The second-largest hospital was also found in China. No U.S. hospital made the world top 20 list, although AdventHealth Orlando was close, being the largest hospital in the United States.

The global hospital appointment scheduling system market is experiencing robust growth, driven by the increasing need for efficient patient management and improved healthcare delivery. The market's expansion is fueled by several key factors: a rising global population coupled with an aging demographic demanding more healthcare services, the escalating adoption of electronic health records (EHRs) and integrated healthcare systems, and a growing emphasis on patient convenience and satisfaction. The shift towards value-based care models further incentivizes hospitals and clinics to optimize appointment scheduling to reduce wait times, improve resource allocation, and enhance overall operational efficiency. Technological advancements, including the development of user-friendly mobile applications and sophisticated appointment scheduling software with features like automated reminders and online patient portals, are also significantly impacting market growth. Competition is intense, with a mix of established players and emerging tech companies vying for market share. The market is segmented by application (hospital, clinic, others) and by the size of the hospital system (small and medium, large). The large hospital system segment is projected to hold a significant share due to higher investment capacity and a greater need for robust scheduling solutions. Geographic expansion is another key factor, with North America and Europe currently leading the market, while Asia-Pacific is expected to witness substantial growth in the coming years, driven by increasing healthcare infrastructure development and rising disposable incomes. While the market presents significant opportunities, challenges remain. High initial investment costs associated with implementing new systems can be a barrier for smaller clinics and hospitals. Data security and privacy concerns related to patient information also need careful consideration. Furthermore, the integration of new appointment systems with existing legacy systems within healthcare organizations can present technical challenges. Successfully overcoming these obstacles will be crucial for sustained market growth. The increasing adoption of cloud-based solutions and the development of interoperable systems are expected to mitigate some of these challenges and fuel further market expansion throughout the forecast period. Market consolidation through mergers and acquisitions is also anticipated, leading to a more concentrated competitive landscape. The overall outlook for the hospital appointment scheduling system market remains optimistic, with a projected substantial increase in market value over the next decade.

NC Center for Geographic Information and Analysis developed the digital Hospital Locations data from hospital addresses provided by the State Center for Health Statistics This file enables users to identify hospital locations. This data covers the entire extent of North Carolina. This data was created to assist governmental agencies and others in making resource management decisions through use of a Geographic Information System (GIS).

Overview

New York, NY – Aug 04, 2025 : The Global Hospital Outsourcing Market is projected to reach US$ 976.9 billion by 2034, up from US$ 366.5 billion in 2024. This reflects a CAGR of 10.3% from 2025 to 2034. North America leads the market, holding a 65.6% share and a value of US$ 240.4 billion in 2024. Growth is fueled by rising demand for external support across healthcare operations. As hospitals focus on core clinical services, outsourcing remains key to streamlining operations, boosting efficiency, and ensuring quality care delivery across regions.

One major driver of outsourcing is the global workforce shortage. The WHO reports a 29% increase in health workers from 2016 to 2020, totaling 65 million. However, a gap of 10 million workers is expected by 2030, especially in low- and middle-income countries. To manage care delivery, hospitals increasingly outsource non-core services. Tasks like housekeeping, billing, and IT support are handled externally. This approach helps hospitals cope with staffing gaps while maintaining continuous patient care without compromising quality or safety.

Cost efficiency is another critical factor. A study revealed that 54% of healthcare CFOs believe outsourcing enhances operational and financial performance. By outsourcing services such as cleaning, catering, and admin tasks, hospitals reduce expenses and focus resources on clinical areas. This strategy supports better use of internal budgets. It also ensures that patient care remains the top priority. Efficient cost management through outsourcing allows healthcare systems to remain financially stable while improving workflow and service delivery.

Quality assurance and regulatory compliance further support outsourcing growth. Specialized providers follow strict quality protocols and health regulations. Their expertise helps hospitals maintain high standards in safety and patient outcomes. For example, outsourced labs and diagnostic services use certified processes that match national healthcare guidelines. This ensures reliability and minimizes patient risk. As a result, hospitals benefit from better service consistency, fewer compliance issues, and enhanced patient satisfaction. Trust in third-party partners is now essential for operational success.

Technology and sustainability are also reshaping the outsourcing landscape. Hospitals outsource telemedicine, diagnostics, and facility management to advanced providers. During COVID-19, telehealth services were widely outsourced to manage remote care. Hospitals also pursue green partnerships to reduce carbon footprints. For instance, Queen’s Medical Centre in the UK launched a £15 million energy project to cut 10,000 tonnes of CO₂ annually. Waste outsourcing is also rising. Facilities like Cleveland Clinic now divert 40% of waste from landfills. These steps show how outsourcing supports efficiency and environmental goals.

Haemodialysis Machine Market Outlook

The global haemodialysis machine market size was valued at approximately USD 12.8 billion in 2023 and is projected to reach around USD 21.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period. The primary growth drivers for this market include the increasing prevalence of chronic kidney diseases (CKD), technological advancements in haemodialysis machines, and a rising aging population globally, which is more susceptible to kidney-related ailments.

One of the significant growth factors in the haemodialysis machine market is the rising incidence of chronic kidney diseases. This condition often leads to end-stage renal disease (ESRD), necessitating dialysis. According to the Global Burden of Disease study, CKD is one of the top 10 causes of death globally, putting considerable pressure on healthcare systems to manage and treat this condition. This increasing burden is expected to drive the demand for haemodialysis machines significantly.

Technological advancements in haemodialysis machines are another major growth driver. Innovations such as portable and wearable haemodialysis machines are providing patients with more flexible treatment options. These advanced machines improve the quality of life by allowing patients to undergo dialysis at home or on the go, thus reducing the need for frequent hospital visits. The integration of smart technologies and real-time monitoring systems in these machines also enhances patient safety and treatment efficacy, adding to their growing adoption.

Additionally, the aging global population is contributing to the market's expansion. Older adults are more likely to suffer from CKD and other renal issues, thereby increasing the demand for haemodialysis machines. According to the United Nations, the global population aged 65 and older is growing faster than all other age groups, which is expected to double by 2050. This demographic shift is likely to create substantial opportunities for the haemodialysis machine market.

Regionally, the market outlook for haemodialysis machines varies. North America currently holds the largest market share, driven by well-established healthcare infrastructure, high healthcare expenditure, and a rising prevalence of CKD. However, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period, fueled by increasing healthcare investments, improving healthcare infrastructure, and a growing awareness about CKD and its treatment options.

Product Type Analysis

The product type segment of the haemodialysis machine market comprises conventional haemodialysis machines, portable haemodialysis machines, and wearable haemodialysis machines. Conventional haemodialysis machines currently dominate the market due to their widespread use in hospitals and dialysis centers. These machines have been the standard in dialysis treatment for several years and continue to be a reliable option for many healthcare providers. Despite their larger size and the necessity for a fixed location, their efficacy and reliability make them a staple in the market.

Portable haemodialysis machines are emerging as a significant segment within the haemodialysis machine market. These machines offer the advantage of mobility, allowing patients to undergo dialysis in various locations, including their homes. The convenience and flexibility provided by portable machines are particularly beneficial for patients with busy schedules or those who find frequent hospital visits cumbersome. This segment is expected to grow rapidly, driven by technological advancements that enhance the portability and functionality of these machines.

Wearable haemodialysis machines represent the frontier of innovation in this market. These devices are designed to be worn by patients, offering unprecedented freedom and significantly improving the quality of life. Although still in the early stages of adoption, wearable haemodialysis machines hold immense potential due to their ability to provide continuous dialysis treatment without restricting the patient's mobility. This segment is anticipated to witness substantial growth as technology advances and more wearable options become available.

In the conventional haemodialysis machines segment, ongoing research and development are focused on improving the efficiency and safety of these machines. Key areas of innovation include enhancing the precision of fluid removal and minimizing the risks of complications such as infection